SPSS 20.0 software system (IBM, SPSS, Chicago, IL, USA) was used for statistical analysis. All data were represented as means ± standard deviation (S.D.). A Student’s t test was applied to analyze the differences in AB073614 levels between GBM tissues and normal brain tissues. Pearson’s Chi-square test or Fisher’s exact test was performed to determine the relationship between lncRNA AB073614 expression levels and clinicopathological characteristics. Kaplan-Meier method was used to evaluate the overall survival rates, and the log-rank test was performed to calculate the difference in survival. The Cox proportional hazards regression model was used for univariate and multivariate analyses to assess the effects of the clinicopathological variables and AB073614 mRNA expression levels on overall survival. A p-value of <0.05 was considered statistically significant.
Spss 20.0 software system
Manufactured by IBM
Sourced in United States
SPSS 20.0 is a statistical software system developed by IBM. It provides tools for data analysis, data management, and data visualization. The software enables users to perform various statistical analyses, including regression, correlation, and hypothesis testing.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using spss 20.0 software system
1
Analyzing lncRNA AB073614 in Glioblastoma
2
Statistical Analysis of LINC01186 Expression
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
The SPSS 20.0 software system (IBM Corp., Armonk, NY, USA) was used for statistical analyses. The results are showed as the mean ± SD (standard deviation) from at least three independent experiments. The chi-square test was applied to examine the relationship between LINC01186 expression and clinicopathological characteristics. Significant differences between two groups were compared using two-tailed Student's t-tests. Significant differences among multiple groups were performed using one-way analysis of variance followed by a Bonferroni post hoc test. P<0.05 was considered to indicate a statistically significant difference.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!